A significant positive correlation was found between PLA1A and disease severity as well as diagnostic markers, thus PLA1A could be used in the future as a non-invasive marker in the diagnosis and therapy of metastatic melanomas. This evidence concerns the gene PLA1A and metastatic melanoma.